Pharmacokinetics

The pharmacokinetic characteristics of tocainide:

Oral bioavailability Onset of action Peak response Duration of action Plasma half-life

Approximately 100% Not known 0.5-2 hours 8 hours 15 hours

Primary route of metabolism Primary route of excretion Therapeutic serum

Clinical Uses

Hepatic

Renal (40% unchanged) 3-11 ^g /mL concentration

Tocainide is indicated for the treatment of symptomatic ventricular arrhythmias refractory to more conventional therapy. Serious noncardiac adverse effects limit its use to patients with life-threatening arrhythmias.

Peripheral Neuropathy Natural Treatment Options

Peripheral Neuropathy Natural Treatment Options

This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.

Get My Free Ebook


Post a comment